Memphis Pharmaceuticals & Chemical Industries

E£326.90As of Sun 8 Nov 2026, 12:00 UTC
EGX:MPCIHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 60.81%
Div yield 4.03%
ROE 59.48%
Pharmaceutical Preparations
Beta (5Y) 0.12
PE TTM 15.49
TSR TTM 78.39%
Mkt cap E£7.437B
ROIC 137.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£403
23.21%
210.77%
Hold 9|1|8|1|2
2Q26
3Q26
4Q26
1Q27
Earnings per shareE£
5.24
5.77
5.69
5.86
(1.51%)
7.72%
3.02%
6.58%
RevenueE£M
467.5
486.3
489.8
516.3
(3.36%)
(1.92%)
(0.33%)
7.89%
Peers (US$133.9M)
Cap (US$)
PE
124.0M
14.37x
136.0M
1,303x
Capital
TTM
5Y
10Y
Leveragex
1.956
0.025
0.027
EBIT/Intx
2.339
0.147
0.138
Own earn%
90.56
22.68
27.45
Sh yield%
20.25
10.87
10.38
Owners
Insiders/Inst%
12.93
43.26
Short interest%
2.40
SBC / revenue%
5.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
22